Search Results - "Vicente Valor, J"

5PSQ-119 A new pharmaceutical care programme for COVID-19 patients treated with Paxlovid®: Implementation and safety outcomes reported by Ferris Villanueva, M, Chamorro de Vega, E, Gonzalez Rodriguez, CG, Torroba Sanz, B, Vicente Valor, J, Herranz Alonso, A, Sanjurjo Sáez, M

“…Background and ImportanceThe COVID-19 pandemic has highlighted the important role that hospital pharmacists play in improving pharmacotherapy outcomes…”
Get full text

5PSQ-117 Evaluation of cardiotoxicity by osimertinib in clinical practice by Ruiz Briones, P, Escudero Vilaplana, V, Collado Borell, R, Vicente Valor, J, Villanueva Bueno, C, Narrillos Moraza, A, Somoza Fernández, B, Herrero Bermejo, S, Gomez Costas, D, Herranz Alonso, A, Sanjurjo Saez, M

“…Background and ImportanceOsimertinib is a tyrosine kinase inhibitor (TKI) indicated for the treatment of epidermal growth factor receptor mutated…”
Get full text

3PC-040 Galenic validation of a dexamethasone 0.01% mouthwash solution to prevent everolimus related stomatitis by Vicente Valor, J, Herrero Revuelta, JL, Pernia López, MS, Herranz Alonso, A, Sanjurjo Sáez, M

“…Background and importanceStomatitis is a common adverse drug reaction of the mTOR inhibitor everolimus. Rugo et al (2016) reported that the use of a…”
Get full text

5PSQ-134 Analysis of factors related to the clinical course of COVID-19 infection in patients with hypertension by Garcia Moreno, FJ, Chamorro De Vega, E, Rodriguez Gonzalez, C, Melgarejo Ortuño, A, Vicente Valor, J, Somoza Fernandez, B, Taladriz Sender, I, Villanueva Bueno, C, De Lorenzo Pinto, A, Herranz Alonso, A, Sanjurjo Saez, M

“…Background and importanceIdentification of the angiotensin converting enzyme (ACE2) as a target of the SARS-CoV-2 virus raises questions about a possible…”
Get full text

4CPS-238 Evaluation of effectiveness of compounded oral vancomycin capsules for treatment of Clostridium difficile infection by Moraza, Á Narrillos, Pernía López, MS, Olmedo Samperio, M, Chamorro De Vega, E, Rodriguez Gonzalez, C, Vicente Valor, J, Somoza Fernández, B, Ruiz Briones, P, Herranz Alonso, A, Sanjurjo Saez, M

“…Background and importanceOral vancomycin (125 mg four times daily) is the standard treatment for mild/moderate Clostridium difficile infection (CDI). As there…”
Get full text

4CPS-282 Epidemiology and clinical course of patients with cancer diagnosed with SARS-CoV-2 infection by Taladriz Sender, I, Garcia Moreno, FJ, Villanueva Bueno, C, Vicente Valor, J, Revuelta Herrero, JL, Collado Borell, R, Escudero Vilaplana, V, Gonzalez-Haba Peña, E, Sanjurjo Saez, M

“…Background and importanceCancer patients are a vulnerable population for SAR-CoV-2 infection.Aim and objectivesThe aim of our study was to describe the…”
Get full text